CliffBio
small molecule

FOSAMAX PLUS D

ALENDRONATE SODIUM; CHOLECALCIFEROL

Loss of exclusivity—loss of exclusivity
CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand nameFOSAMAX PLUS D
Active ingredientALENDRONATE SODIUM; CHOLECALCIFEROL
StrengthEQ 70MG BASE;5,600 IU
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2007
Marketing statusRX

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FOSAMAX PLUS D patent cliff — loss of exclusivity — | CliffBio